Navigation Links
European patient registry in venous thromboembolism (VTE) - PREFER in VTE - enrols first patient
Date:2/6/2013

MUNICH, February 6, 2013 /PRNewswire/ --

The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the clinical management of a disease that is a leading cause of morbidity and mortality[1]

Daiichi Sankyo Europe GmbH announced the enrolment of the first patient into the PREvention oF thromboembolic events - European Registry in Venous ThromboEmbolism (PREFER in VTE).  PREFER in VTE is the first patient registry to gather comprehensive data on the quality of life and treatment satisfaction of patients with VTE. It will also provide detailed insights into the process of patient management in the acute treatment phase, as well as in the prevention of repeat thromboembolic events. In addition, the PREFER in VTE registry will investigate the economic burden of VTE treatment.  

Discussing the importance of this registry, Dr. Alexander T. Cohen , Honorary Consultant Vascular Medicine, Department of Vascular Surgery, King's College Hospital, London, said, "The enrolment of the first patient in this registry is an exciting milestone. PREFER in VTE is the first registry of its kind that will provide detailed insight into the patient's perspective. Relying on patient interviews and diaries rather than focusing purely on a doctor's assessment of VTE, will give us important patient data outside of a clinical trial setting."

VTE is a leading cause of morbidity and mortality worldwide and the annual number of VTE-related deaths has been estimated at more than 500,000 across the EU.[1] Results of literature reviews have shown that VTE, and its consequences, have considerable economic impacts on healthcare systems.[2]

The PREFER in VTE registry plans to enrol more than 4,000 patients with VTE (deep vein thrombos
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
2. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
5. Mylan Launches Generic Lipitor® in Five European Countries
6. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
7. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
8. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
9. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
10. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... a leader in R&D for new therapeutic solutions for the ... Growth Factor) has been designated as an orphan drug by ... The candidate drug, developed by the research of Dompe, has ... neurotrophic keratitis, a degenerative corneal disease that affects less than ... a cure. This is the second orphan drug designation by ...
(Date:7/23/2014)... July 23, 2014 Research and ... "Prepackaged Medical Kits and Trays - Global ... http://photos.prnewswire.com/prnh/20130307/600769 ... Prepackaged Medical Kits and Trays in US$ Thousands ... Ophthalmic Custom Trays, Custom Basin Kits, Custom Ob/Gyn ...
(Date:7/23/2014)...  ArmaGen, a privately held biotechnology company focused ... disorders, announced today that it has entered into ... plc to develop AGT-182, an investigational enzyme replacement ... central nervous system (CNS) and somatic (body-related) manifestations ... Hunter syndrome is a rare, severe, progressive and ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3
... VacChina 2011 - - ... - - welcomes world class ... vaccine R&D and manufacturing technologies in China. The ... national regulatory authority of China -- the State Food and Drug ...
... Aug. 18, 2011 Generex Biotechnology Corporation (OTCBB: ... Company,s wholly-owned subsidiary Antigen Express, Inc. ( www.antigenexpress.com ... 2 trial with an off-the-shelf immunotherapeutic cancer vaccine, ... Healthtech Institute,s Sixth Annual ImVacS: The Immunotherapeutics and ...
Cached Medicine Technology:VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 3Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 4
(Date:7/23/2014)... 23, 2014 SafeUseNow? , ... program developed by Principled Strategies , today ... of California . Utilizing SafeUseNow’s patent-pending risk model, ... of misusing and abusing controlled substance drugs, particularly ... among its members. , The agreement with Partnership ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The European ... fertilizers market in Europe with analysis and forecast of ... to grow from around $ 2,566.4 million in 2012 ... 12.3%, from 2012 to 2017. , Browse through the ... get an idea of the in-depth analysis provided. ...
(Date:7/23/2014)... workplaces may need to consider innovative methods to prevent ... on results from a new study published in the ... JOEH ), workers who are obese may have significantly ... their non-obese counterparts. , The study, conducted at ... 32 individuals in four categories (non-obese young, obese young, ...
(Date:7/23/2014)... athletes who suffered repeated blows to the head during ... Those clumps suggest the athletes had a disease called ... tests that might be able to detect CTE in ... Chemical & Engineering News (C&EN) , the weekly news ... article, Lauren Wolf, a senior editor at C&EN, explains ...
(Date:7/23/2014)... Jose, CA (PRWEB) July 23, 2014 ... computing and collaboration, today announce that it has ... has established interoperability between Splashtop Enterprise and RSA ... Division of EMC (EMC). , Splashtop ... Asset Management is now deploying Splashtop Enterprise, the ...
Breaking Medicine News(10 mins):Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Obesity linked to low endurance, increased fatigue in the workplace 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3
... several previous studies, Geoffrey R. Howe, Ph.D., of Columbia ... that exposure// to radioactive substances increased cancer risks in ... a study conducted to examine the cancer prevalence showed ... adolescents who are exposed to radioactive iodine. ...
... Medical Association (AMA) has issued a warning that the nation ... due to a lack of clinical expertise. ,Dr ... MPs and senators insisting for a strategy be put in ... number of students. He stated that there would be a ...
... show that the number of sexually transmitted infections is on ... 2005 there was a 3 percent rise in the diagnosis ... increase was reported in syphilis cases at 23 percent, but ... cases of gonorrhea fell by 13 percent. The highest increase ...
... that inhabitants of Phet where hundreds of poultry died last ... a feast on these birds. ,Public health officials ... create awareness of bird flu after hundreds of chicken died ... after a visit to the area that people were disregarding ...
... Kalam, who is on a three-day visit to Orissa, was ... the state board examination despite suffering// from an eye disorder ... the Bhubaneswar Eye Institute (BEI) located on the outskirts of ... and hoped doctors of the institute would find a cure. ...
... and biological timing in the body work much differently ... approach to making drugs for sleep disorders and depression ... an about-face from previous research, said Daniel Forger, assistant ... and his collaborators from the University of Utah's Huntsman ...
Cached Medicine News:Health News:Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine 2Health News:New Sleep Gene Discovery Wakes Up Scientists 2
Townsend is a endocervical stainless-steel curette with round tapered tip....
...
...
...
Medicine Products: